2m 2m 2m 2m 2m 2m 2m
LANTERN PHARMA (LTRN)
NASDAQ
$0.50+$0.02 (+3.33%)
Price as of Nov 12, 2026 8:34 AM EST- $7.2MMarket Cap
- -86.18%1-Year Change
- BiotechnologyIndustry
LANTERN PHARMA (LTRN)
$0.50+$0.02 (+3.33%)
LTRN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.48 | ||
Change | +$0.02 (+3.89%) | ||
Open | $0.51 | ||
High | $0.51 | ||
Low | $0.47 | ||
Previous Close | $0.46 | ||
Volume | 157,203 | ||
30-Day Average Volume | 266,494 | ||
1-Week Change | -18.00% | ||
1-Month Change | -40.81% | ||
1-Year Change | -86.18% | ||
3-Year Change | -85.42% | ||
5-Year Change | -95.04% | ||
Fundamentals | |||
Shares Outstanding | 14.9M | ||
Total Assets | $8.6M | ||
Market Cap | $7.2M | ||
Enterprise Value | $523,842.00 | ||
Period: QTR TTM FY | |||
Revenue | $27,238.00 | ||
Net Income | -$7.1M | ||
Free Cash Flow | -$2.9M | ||
EBIT | -$7.1M | ||
EBITDA | -$7.1M | ||
Net Working Capital | $4.1M | ||
EPS | -$0.57 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | 19 | ||
P/B | N/A | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue